52 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28603989	53	a-Conotoxin [S9A]TxID Potently Discriminates betweena3ß4 anda6/a3ß4 Nicotinic Acetylcholine Receptors.	Hainan University
28337332	41	BMS-933043, a Selectivea7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.	Bristol-Myers Squibb
27958732	93	Design and Synthesis of a New Series of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes asa7 Nicotinic Receptor Agonists. 1. Development of Pharmacophore and Early Structure-Activity Relationship.	Bristol-Myers Squibb
27639361	88	Synthesis and biological evaluation of novel hybrids of highly potent and selectivea4ß2-Nicotinic acetylcholine receptor (nAChR) partial agonists.	University of Illinois At Chicago
24844195	21	Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A.	Georgetown University Medical Center
24187998	96	Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.	University of Copenhagen
24649848	47	Discovery of a potent and selectivea3ß4 nicotinic acetylcholine receptor antagonist from ana-conotoxin synthetic combinatorial library.	Torrey Pines Institute For Molecular Studies
15050615	36	Synthesis and pharmacological characterization of bivalent ligands of epibatidine at neuronal nicotinic acetylcholine receptors.	University of Illinois At Chicago
24428686	6	Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.	Research Triangle Institute
24274400	28	Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies.	Torrey Pines Institute For Molecular Studies
24200193	32	Characterization of a novela-conotoxin TxID from Conus textile that potently blocks rata3ß4 nicotinic acetylcholine receptors.	Hainan University
24047231	52	Design, synthesis and discovery of picomolar selective α4β2 nicotinic acetylcholine receptor ligands.	Georgetown University
15686946	36	Halogenated and isosteric cytisine derivatives with increased affinity and functional activity at nicotinic acetylcholine receptors.	National Institute of Diabetes and Digestive and Kidney Diseases
22410083	17	Consequences of linker length alteration of thea7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333.	The University of Sydney
18989912	95	Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.	University of Copenhagen
18605717	41	Discovery of (-)-7-methyl-2-exo-[3'-(6-[18F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane, a radiolabeled antagonist for cerebral nicotinic acetylcholine receptor (alpha4beta2-nAChR) with optimal positron emission tomography imaging properties.	The Johns Hopkins University School of Medicine
15050613	50	Pharmacology of the agonist binding sites of rat neuronal nicotinic receptor subtypes expressed in HEK 293 cells.	Georgetown University School of Medicine
11354387	20	Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues.	University of Kentucky
20979364	40	Novela3ß4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.	Sri International
19481945	55	Synthesis and biological evaluation of novel carbon-11 labeled pyridyl ethers: candidate ligands for in vivo imaging of alpha4beta2 nicotinic acetylcholine receptors (alpha4beta2-nAChRs) in the brain with positron emission tomography.	The Johns Hopkins University School of Medicine
17067175	3	Isolation, structure elucidation, and biological evaluation of 15-amido-3-demethoxy-2alpha,3alpha-methylenedioxyerythroculine, a new alkaloid from Hyperbaena valida.	Glaxosmithkline
16005216	20	The characterization of a novel rigid nicotine analog with alpha7-selective nAChR agonist activity and modulation of agonist properties by boron inclusion.	University of Florida
15771418	38	Novel pyridyl ring C5 substituted analogues of epibatidine and 3-(1-methyl-2(S)-pyrrolidinylmethoxy)pyridine (A-84543) as highly selective agents for neuronal nicotinic acetylcholine receptors containing beta2 subunits.	University of Illinois At Chicago
15050621	100	Epibatidine structure-activity relationships.	Research Triangle Institute
14971903	17	Chemical and functional identification and characterization of novel sulfated alpha-conotoxins from the cone snail Conus anemone.	The University of Queensland
31986036	89	Structure and Activity Studies of Disulfide-Deficient Analogues of ?O-Conotoxin GeXIVA.	Hainan University
31194549	57	PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets ?3?2 Nicotinic Acetylcholine Receptors.	Veterans Affairs Medical Center
26298493	133	Conformationally restrained carbamoylcholine homologues. Synthesis, pharmacology at neuronal nicotinic acetylcholine receptors and biostructural considerations.	Iqm-Csic
25050162	78	Synthesis and Pharmacological Evaluation of DH?E Analogues as Neuronal Nicotinic Acetylcholine Receptor Antagonists.	University of Copenhagen
25464883	11	Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of ?3?4 nicotinic acetylcholine receptor.	Medical University of Lublin
16640326	104	Synthesis and pharmacological evaluation of novel 9- and 10-substituted cytisine derivatives. Nicotinic ligands of enhanced subtype selectivity.	University of Illinois At Chicago
16039849	84	Epibatidine analogues as selective ligands for the alpha(x)beta2-containing subtypes of nicotinic acetylcholine receptors.	Columbia University College of Physicians and Surgeons
16078832	25	Ligand selectivity for the acetylcholine binding site of the rat alpha4beta2 and alpha3beta4 nicotinic subtypes investigated by molecular docking.	Swiss Federal Institute of Technology Zurich
15925512	23	6-(2-Phenylethyl)nicotine: a novel nicotinic cholinergic receptor ligand.	Virginia Commonwealth University
12620069	42	Synthesis, nicotinic acetylcholine receptor binding affinities, and molecular modeling of constrained epibatidine analogues.	Georgetown University Medical Center
29671588	35	Absolute Configuration and Pharmacology of the Poison Frog Alkaloid Phantasmidine.	Indiana State University
30252466	37	Single Amino Acid Substitution in ?-Conotoxin TxID Reveals a Specific ?3?4 Nicotinic Acetylcholine Receptor Antagonist.	Hainan University
29050783	40	Design and synthesis of a novel series of (1'S,2R,4'S)-3H-4'-azaspiro[benzo[4,5]imidazo[2,1-b]oxazole-2,2'-bicyclo[2.2.2]octanes] with high affinity for the ?7 neuronal nicotinic receptor.	Bristol-Myers Squibb Pharmaceutical Research Institute
29384668	249	Dual Nicotinic Acetylcholine Receptor ?4?2 Antagonists/?7 Agonists: Synthesis, Docking Studies, and Pharmacological Evaluation of Tetrahydroisoquinolines and Tetrahydroisoquinolinium Salts.	University of Copenhagen
29178785	61	Highly Selective and Potent?4?2 nAChR Antagonist Inhibits Nicotine Self-Administration and Reinstatement in Rats.	Torrey Pines Institute For Molecular Studies